Skip to content

Ali J Zarrabi

5 papers in the library · 17 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.

medRxiv : the preprint server for health sciences July 14, 2026 Ali J Zarrabi, Tanja Mletzko, George H. Grant et al.

Demoralization, a syndrome of helplessness, hopelessness, and loss of meaning and chronic pain are common sources of distress in early palliative care. Psilocybin-assisted therapy (PAT) is an emerging intervention with preliminary data suggesting improvements in pain and demoralization. To date, PAT has not been studied among people living with both demoralization and chronic pain nor has it...

Attitudes of U.S. Muslims Toward Psychedelics.

Psychedelic medicine (New Rochelle, N.Y.) March 1, 2026 Syed F. Rab, Salman S Ahmad, Roman Palitsky et al. 1 citation

Muslims living in the United States (MLUS) are underrepresented in psychedelics research. Despite growing research on psychedelic-assisted mental health care, little is known about its acceptance among MLUS, a population with some history of rejecting mental health services. This study examined whether MLUS' rejection attitudes toward mental health services were related to lower acceptance of...

A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.

Psychotherapy January 13, 2025 Roman Palitsky, Jessica L Maples-Keller, Caroline Peacock et al. 13 citations

Psilocybin-assisted therapy (PAT) is an experimental treatment with transformative promise. Developing standards for PAT psychotherapy protocols is a priority, but psychotherapeutic protocol components of PAT have been subjected to little rigorous research. This study was designed to assess protocol components in a trial of PAT. The Enhanced Critical Incident Technique (E-CIT) was used to...

Psilocybin decelerates cellular senescence

Research Square June 27, 2023 Louise Hecker, Kosuke Kato, Jennifer Kleinhenz et al.

Abstract Psilocybin is the psychoactive substance contained in the psilocybe(hallucinogenic) mushroom, which has received considerable attention among the scientific community in recent years. Human studies have demonstrated that even a single-dose of psilocybin can improve debilitating physical and psychological symptoms with durable long-term effects. >136 clinical studies with psilocybin...